<DOC>
	<DOCNO>NCT01487512</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics OROS Hydromorphone healthy adult Taiwanese participant oral administration 4 different dose strength 8 , 16 , 32 64 mg fast condition .</brief_summary>
	<brief_title>Effect Dose Pharmacokinetics OROS Hydromorphone Under Fasted Conditions Healthy Taiwanese Participants</brief_title>
	<detailed_description>This single-center , randomize ( study drug assign chance like flip coin ) , open-label ( people involve know identity intervention ) , 4-way crossover ( participant receive different intervention sequentially trial ) study healthy adult Taiwanese participant . All participant randomly assign 1 4 different possible treatment sequence receive treatment order specify randomization schedule . The study consist screen phase , open-label treatment phase consist 4 single-dose treatment period , end-of-study withdrawal assessment . During open-label treatment period , participant stay center completion 72-hour pharmacokinetics [ PK ] ( drug absorb body , distribute within body , remove body time ) blood sample Day 4 . A 7- 14-day washout period ( period receive treatment ) separate open-label treatment period . The safety tolerability evaluate investigated dose range . The duration participation study individual participant approximately 12 week .</detailed_description>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>Body mass index ( BMI ) 18 25 kg/mÂ² , inclusive body weight less 50 kg Participants must utilize medically acceptable method contraception throughout entire study period 1 month study complete Each participant receive naloxone challenge test opioid dependency screen . Only participant pass challenge test allow continue study History current clinically medical illness condition investigator considers exclude participant could interfere interpretation study result Clinically significant abnormal value hematology , clinical chemistry urinalysis Clinically significant abnormal physical examination , vital sign 12 lead electrocardiogram ( ECG ) Use certain prescription nonprescription medication , consumption product may interfere study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Dose Proportionality</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>OROS Hydromorphone</keyword>
	<keyword>Hydromorphone</keyword>
	<keyword>Taiwan</keyword>
</DOC>